Janus Henderson Group
CNST

Janus Henderson Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Janus Henderson Group’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-122,901
Closed -$4.16M – 2252
2021
Q2 		$4.16M Buy
+122,901
New +$3.13M ﹤0.01% 1101

Janus Henderson Group's CNST Position: Q3 2021 in Review

Janus Henderson Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 122,901 shares — an estimated $4.16M sold.

Janus Henderson Group first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $4.16M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Janus Henderson Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Janus Henderson Group sold 122,901 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $4.16M.
  • Janus Henderson Group first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Janus Henderson Group's Constellation Pharmaceuticals, Inc. position peaked at $4.16M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Janus Henderson Group's 13F filing for Q3 2021, filed 16 Nov 2021.